Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Graha Mitra Asia Tbk. (RELF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Graha Mitra Asia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp228 (market cap 319B, 124.3K 24h volume), while Graha Mitra Asia Tbk. trades at Rp35 (market cap 194.75B, 2.1M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Graha Mitra Asia Tbk. is more actively traded (2.1M versus 124.3K). Which is the better fit depends on your goals.
| DGNS | RELF | |
|---|---|---|
Market Cap | 319B | 194.75B |
Volume | 124.3K | 2.1M |
Lot | 1.24K | 20.97K |
Turnover | 28.28M | 71.16M |
Average Price | 227.48 | 33.93 |
Value | 28.28M | 71.16M |
Indicative Equilibrium Price | 228 | 35 |
Indicative Equilibrium Volume | 100 | 90 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Graha Mitra Asia Tbk.
PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.
Read more on RELF →
